IlluminaILMN

NASDAQ · USA · Segment 5 of 8 in the Medicine, pharma & life science value chain: Life science tools

American leader in DNA sequencing — instruments and consumables used in research and clinical genomics.

Life science tools: Instruments, reagents and equipment for research, development and production.

Key metrics

Market cap

$29.3B

Price

$191.08

Today

−1.4%

Return YTD

+47.7%

Return 1Y

+98.9%

P/E

34.3

P/S

6.7

P/B

10.9

Data as of 2026-07-10 · updates daily after U.S. close

Theme exposure

Genome sequencingLife science toolsDiagnostics exposureClinical genomics

In the value chain

Products & services

Sequencing instruments
Consumables (reagents)
Genomics software

Competitors

Thermo Fisher
PacBio
MGI

Risks

Competition in sequencing
Cyclical research demand

Same segment: Life science tools

Thermo Fisher ScientificTMO DanaherDHR Waters CorporationWAT Agilent TechnologiesA RevvityRVTY

See where Illumina sits in the full Medicine, pharma & life science map — every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →